Achieve Life Sciences to report Q1 2026 results and update on nicotine dependence drug cytisinicline on May 12.

Clinical OMICsHeart Attack Byproduct Linked to Brain Inflammation and Cognitive Decline

Endpoints NewsPost-Hoc Live: Jeremy Levin on biotech's existential moment

Endpoints NewsOutlook says FDA will sign off on its version of Avastin for wet AMD

BioPharma DiveEarly data for heart drug affirm Lilly’s billion-dollar bet on Verve

BioPharma DiveLilly dives into vaccine research with 3 biotech buyouts

FierceBiotechMakary’s FDA reforms ‘continue to move forward’ despite leadership turmoil

Clinical OMICsGPS Tracking Upends Rural Uganda’s Schistosomiasis Transmission Assumptions

Endpoints NewsCartesian secures funding to 'accelerate' launch; Editas sells $125M in stock

Endpoints NewsCan AI do scientific research? Billions chase hopes of superintelligence

BioWorldLilly buys three vaccine makers; PCSK9 base editor shows promise

BioWorldChina’s new IIT rules expected to wipe out ‘gray market’

BioWorldDaewoong takes over Turn Bio’s longevity platform from Hanall